GS-441524 for Cats with FIP

Learn how GS-441524 works for cats with FIP, including oral tablets, dosage guidance, treatment monitoring, safety, research, approval status, and access options.

GS-441524 INFORMATION CENTER

How to Choose a GS-441524 Product

Learn about GS-441524 for cats with feline infectious peritonitis, including how it works, approval status, oral tablet options, product verification, batch traceability, and NeoFipronis® Pronidesivir tablets.

View NeoFipronis® Tablets FIP Treatment Guide

30 mg Oral Tablets

NeoFipronis®

Registered oral GS-441524 tablets for cats, also known as Pronidesivir, with product verification and batch traceability support.

30 mg Per Tablet

30 Tablets / Box

900 mg Total GS-441524

Antiviral Compound Widely discussed for cats with FIP

Oral Tablet Options Convenient at-home administration

Approval Status Regulatory status varies by country

Batch Traceability Product source and verification matter

OVERVIEW

What Is GS-441524?

GS-441524 is a nucleoside analog antiviral compound widely discussed in relation to feline infectious peritonitis. In the NeoFipronis® product context, GS-441524 is also known as Pronidesivir.

Active Ingredient GS-441524

Also Known As Pronidesivir

Related Condition FIP in Cats

Common Forms Oral tablets / injections

MECHANISM

How Does GS-441524 Work?

GS-441524 works by interfering with viral RNA replication. After entering cells, it can be converted into an active form that helps inhibit viral RNA polymerase activity, reducing viral replication.

1 Cell Entry GS-441524 enters target cells.

2 Active Form It is converted into an active form inside cells.

3 RNA Polymerase Inhibition It helps interfere with viral RNA replication.

4 Reduced Viral Replication Viral replication may be reduced with proper guidance.

FIP IN CATS

GS-441524 and FIP in Cats

Feline infectious peritonitis can appear in different forms, including wet FIP, dry FIP, ocular FIP, and neurological FIP. GS-441524 is one of the most discussed antiviral compounds in the FIP community. Product selection and treatment planning should be based on body weight, FIP type, clinical signs, and monitoring results.

Wet FIP Often associated with fluid accumulation and systemic inflammation.

Dry FIP May involve inflammatory lesions in internal organs without obvious fluid buildup.

Ocular FIP May involve eye inflammation, cloudiness, or other ocular signs.

Neurological FIP May involve balance problems, tremors, seizures, or other neurological signs.

REGULATORY STATUS

GS-441524 Approval Status

GS-441524 regulatory status differs by country. Cat owners should understand the difference between FDA approval, compounded availability, and official registration in another country.

United States

GS-441524 is not currently FDA approved as a veterinary drug for FIP in cats. Compounded GS-441524 may be available through veterinary prescription channels under specific conditions.

Laos

GS-441524 has been approved in Laos for feline infectious peritonitis. NeoFipronis® is officially registered in Laos as an oral GS-441524 tablet product for cats.

Other Countries

Regulatory status and availability may vary by country. Cat owners should check local regulations and consult veterinary professionals when possible.

ORAL TABLETS

Oral GS-441524 Tablets for Cats

Oral GS-441524 tablets may be easier for cat owners to administer at home compared with injections. When choosing tablets, cat owners should check the active ingredient, tablet strength, batch number, expiry date, verification method, and registration information.

DOSAGE GUIDANCE

GS-441524 Dosage Guidance for Cats with FIP

GS-441524 dosage is usually calculated based on body weight, FIP type, clinical signs, and treatment response. For many FIP cases, a commonly referenced starting range is 15 mg/kg once daily. Ocular or neurological FIP cases may require higher dosing under professional guidance.

Common Wet / Dry FIP Commonly referenced: 15 mg/kg once daily

Ocular FIP May require higher dosing depending on clinical signs

Neurological FIP Often requires higher dosing and closer monitoring

Treatment Duration Many treatment plans are based on an 84-day course

Dosage should be adjusted according to body weight, FIP type, appetite, clinical response, and monitoring results. Cat owners should avoid changing, stopping, or reducing treatment without professional guidance.

Use Dosage Calculator Ask for Guidance

COMPARISON

GS-441524 Tablets vs. Injections

Both oral and injectable forms require reliable product information and careful monitoring. The right option may depend on the cat’s condition, owner handling ability, product quality, and professional guidance.

Item	Oral Tablets	Injections
Administration	Oral use	Subcutaneous injection
At-home convenience	Generally easier for many owners	Requires injection handling
Stress for cats	Usually lower	May cause stress over time
Skin irritation	No injection-site issue	May cause pain or irritation
Quality requirement	Source, strength, and batch should be verified	Source, concentration, and batch should be verified

PRODUCT QUALITY

What to Check Before Choosing GS-441524

A reliable GS-441524 product should provide clear product information, traceable batches, and support for verification.

Active ingredient clearly listed

Strength per tablet or per mL

Product name and manufacturer information

Batch number and expiry date

Registration information

Product verification support

Clear storage and shipping information

Customer guidance

Honest regulatory claims

IMPORTANT NOTE

Why Unclear-Source GS-441524 Products Are Not Recommended

Unclear-source or black-market GS-441524 products may lack consistent labeling, batch documentation, verification support, registration information, or reliable quality control. Cat owners should be cautious with products that cannot clearly show ingredient, strength, batch number, expiry date, or product source.

NEOFIPRONIS®

NeoFipronis®: Registered Oral GS-441524 Tablets

NeoFipronis® is an oral GS-441524 tablet product for cats. Each tablet contains 30 mg GS-441524, also known as Pronidesivir. NeoFipronis® is officially registered in Laos and supports product verification, batch traceability, and customer guidance.

Product Name NeoFipronis®

Active Ingredient GS-441524 / Pronidesivir

Strength 30 mg per tablet

Form Oral tablet

Pack Size 30 tablets

Total Content 900 mg GS-441524 per box

Registration Officially registered in Laos

Verification Product verification and batch traceability support

PRICE TRANSPARENCY

GS-441524 Cost and Price Transparency

GS-441524 cost can vary depending on cat weight, FIP type, treatment duration, tablet strength, and product source. NeoFipronis® is priced at $168 per box, with 30 tablets per box and 30 mg GS-441524 per tablet.

$168 Per Box

30 Tablets

30 mg Per Tablet

900 mg Total GS-441524

MONITORING

Monitoring During GS-441524 Use

During GS-441524 use, cat owners commonly monitor body weight, appetite, energy level, temperature, stool condition, bloodwork, albumin/globulin ratio, bilirubin, eye signs, neurological signs, and overall response.

Body weight

Appetite

Energy level

Temperature

Stool condition

CBC and biochemistry

Albumin/globulin ratio

Bilirubin

Eye or neurological signs

FAQ

Frequently Asked Questions

What is GS-441524?

GS-441524 is a nucleoside analog antiviral compound widely discussed in relation to feline infectious peritonitis.

Is GS-441524 the same as Pronidesivir?

In the NeoFipronis® product context, GS-441524 is also known as Pronidesivir.

Is GS-441524 used for cats with FIP?

GS-441524 is widely discussed in the FIP community as an antiviral compound related to feline infectious peritonitis.

Is GS-441524 FDA approved?

GS-441524 is not currently FDA approved as a veterinary drug for FIP in cats in the United States. Compounded GS-441524 may be available through veterinary prescription channels under specific conditions.

Is GS-441524 approved in Laos?

GS-441524 has been approved in Laos for feline infectious peritonitis, and NeoFipronis® is officially registered in Laos.

Are GS-441524 tablets available?

Oral GS-441524 tablet options are available in some markets. Cat owners should check product strength, registration information, batch traceability, and verification support.

What is NeoFipronis®?

NeoFipronis® is an oral GS-441524 tablet product for cats. Each tablet contains 30 mg GS-441524, also known as Pronidesivir.

Why should cat owners avoid unclear-source GS-441524?

Unclear-source products may lack ingredient transparency, batch documentation, verification support, registration information, or reliable quality control.

REGISTERED ORAL TABLET OPTION

Looking for a Traceable Oral GS-441524 Tablet Option?

NeoFipronis® provides 30 mg oral GS-441524 tablets for cats, with official registration in Laos, product verification support, batch traceability, and customer guidance.

View Product Contact Support